Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMoneycontrol ResearchWhat ‘second wave’ means for investors in Indian pharma

    What ‘second wave’ means for investors in Indian pharma

    Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma

    Anubhav Sahu
    April 12, 2021 / 10:50 IST
    Volunteers distribute pamphlets during an awareness campaign on the spread of COVID-19 on a street in Mumbai. (Representative image: Reuters)
    • PRO Panorama

      Moneycontrol Pro Panorama | Lessons from Eli Lilly in corporate longevity

      Nov 25, 2025 / 02:43 PM IST

      In Moneycontrol Pro Panorama November 25 edition: Labour Codes do not create flexible work environment legal, rate cuts may revive...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

      Oct 18, 2025 / 10:00 AM IST

      After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More